About Excelsus Statistics
Excelsus Statistics is a company based in Montreal (Canada) founded in 2014 was acquired by Innovaderm in July 2022. Excelsus Statistics offers products and services including Dermatology Clinical Trials and Aesthetics Research. Excelsus Statistics operates in a competitive market with competitors including PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.
- Headquarter Montreal, Canada
- SectorsHealthcare
- Website excelsus-stat.com
- Acquired by Innovaderm (Jul 2022)
- Investors
- Acquired byInnovaderm
(Jul 2022)
Products & Services of Excelsus Statistics
Excelsus Statistics offers a comprehensive portfolio of products and services, including Dermatology Clinical Trials and Aesthetics Research.
Conducts trials for skin conditions and treatments
Focuses on cosmetics and skin aging studies
Investors in Excelsus Statistics
Excelsus Statistics has secured backing from 1 investor. Prominent investors backing the company include Innovaderm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Conducts clinical trials for dermatology research and patient care services. | 2000 | innovaderm.com | Montreal, Canada |
Investor details for Excelsus Statistics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Excelsus Statistics
2 dated milestones of Excelsus Statistics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Excelsus Statistics is founded.
- Exit Acquired by Innovaderm.
Competitors of Excelsus Statistics
Excelsus Statistics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ppd.com | 1985 | Wilmington, United States | – | – | CRO providing diversified clinical development services | |
| cambrianbio.com | 2019 | Brooklyn, United States | $211.46M | – | Medicines and therapies are developed for healthcare applications. | |
| medicuspharma.com | 2008 | Toronto, Canada | – | – | Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry | |
| hugp.com | 1950 | Shinjuku, Japan | – | – | Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns. | |
| dmclinicalresearch.com | 2006 | Houston, United States | – | – | Conducts Phase I-IV clinical trials connecting patients with physicians for medical research. | |
| ipharma.ru | 2012 | Moscow, Russia | – | – | Serves as a contract research organization focused on drug clinical trials. | |
| crh-hamburg.de | 2004 | Hamburg, Germany | – | – | Provider of clinical research of phases II, III and IV from different indications spheres of human medicine | |
| questclinical.com | 2011 | San Francisco, United States | – | – | Provider of clinical research services studies for phase I, II, and III clinical studies |
Detailed competitors of Excelsus Statistics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Excelsus Statistics
10 companies that operate in the same segment as Excelsus Statistics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Excelsus Statistics
Excelsus Statistics was founded in 2014.
Excelsus Statistics is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Excelsus Statistics was founded in 2014 and is headquartered in Montreal, Canada. Operations are centered on contract research organization services within the dermatology sector. Clinical development for dermatology drugs is managed, alongside site management and patient recruitment. Focus is placed on supporting pharmaceutical trials through these specialized activities in the North American market.
Excelsus Statistics's top competitors include PPD, Cambrian BioPharma and Medicus Pharma.
Excelsus Statistics offers Dermatology Clinical Trials and Aesthetics Research.
Excelsus Statistics has 1 investor. Key investors include Innovaderm.
Yes. Excelsus Statistics was acquired by Innovaderm in July 2022.